HN2002000197A - Proceso para la produccion de quinazolinas - Google Patents
Proceso para la produccion de quinazolinasInfo
- Publication number
- HN2002000197A HN2002000197A HN2002000197A HN2002000197A HN2002000197A HN 2002000197 A HN2002000197 A HN 2002000197A HN 2002000197 A HN2002000197 A HN 2002000197A HN 2002000197 A HN2002000197 A HN 2002000197A HN 2002000197 A HN2002000197 A HN 2002000197A
- Authority
- HN
- Honduras
- Prior art keywords
- quinazolins
- production
- useful
- compounds
- quinazoline compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UN NUEVO PROCESO PARA PRODUCIR COMPUESTOS DE QUINAZOLINA QUE SON UTILES EN TERAPIA.- MAS ESPECIFICAMENTE, LOS COMPUESTOS SON ÚTILES EN EL TRATAMIENTO DE LA HIPERPLASIA PROSTATICA BENIGNA. COMPUESTOS DE QUINOLINA Y QUINAZOLINA SUSTITUTIDAS (VER FORMULA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0118752.5A GB0118752D0 (en) | 2001-08-01 | 2001-08-01 | Process for the production of quinazolines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HN2002000197A true HN2002000197A (es) | 2003-02-27 |
Family
ID=9919612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HN2002000197A HN2002000197A (es) | 2001-08-01 | 2002-07-29 | Proceso para la produccion de quinazolinas |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7026479B2 (es) |
| EP (1) | EP1412331B1 (es) |
| JP (1) | JP2005501054A (es) |
| KR (1) | KR20040019097A (es) |
| CN (1) | CN1533378A (es) |
| AP (1) | AP1299A (es) |
| AR (1) | AR036204A1 (es) |
| AT (1) | ATE323677T1 (es) |
| BR (1) | BR0211670A (es) |
| CA (1) | CA2451075A1 (es) |
| CZ (1) | CZ2004151A3 (es) |
| DE (1) | DE60210778T2 (es) |
| DO (1) | DOP2002000443A (es) |
| EG (1) | EG23204A (es) |
| ES (1) | ES2260457T3 (es) |
| GB (1) | GB0118752D0 (es) |
| HN (1) | HN2002000197A (es) |
| HU (1) | HUP0401573A3 (es) |
| IL (1) | IL158998A0 (es) |
| MX (1) | MXPA04000978A (es) |
| PA (1) | PA8550301A1 (es) |
| PE (1) | PE20030346A1 (es) |
| PL (1) | PL368520A1 (es) |
| RU (1) | RU2261861C1 (es) |
| UY (1) | UY27399A1 (es) |
| WO (1) | WO2003011829A1 (es) |
| ZA (1) | ZA200309043B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2280003B1 (en) * | 2002-07-15 | 2014-04-02 | Symphony Evolution, Inc. | Process for preparing receptor-type kinase modulators |
| SI2392564T1 (sl) * | 2003-09-26 | 2014-02-28 | Exelixis, Inc. | c-Met modulatorji in postopki uporabe |
| JP4205757B2 (ja) | 2004-05-06 | 2009-01-07 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | ４−フェニルアミノ−キナゾリン−６−イル−アミド |
| BRPI0714622A2 (pt) * | 2006-08-04 | 2013-04-30 | Merz Pharma Gmbh & Co Kgaa | pirazolopirimidinas substituÍdas, processo para sua preparaÇço e seu uso como medicamento |
| CA2995880C (en) | 2009-01-16 | 2021-01-05 | Exelixis, Inc. | Processes for preparing n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| US9238640B2 (en) | 2009-03-18 | 2016-01-19 | Resverlogix Corp. | Anti-inflammatory agents |
| IN2012DN00352A (es) * | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
| UA108618C2 (uk) | 2009-08-07 | 2015-05-25 | Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку | |
| EP2785346A4 (en) | 2011-11-30 | 2015-04-29 | Bikam Pharmaceuticals Inc | OPSINBINDING LIGANDS, COMPOSITIONS THEREOF, AND METHOD OF USE THEREOF |
| PT2906531T (pt) * | 2012-10-15 | 2018-02-06 | Resverlogix Corp | Compostos úteis na síntese de compostos de benzamida |
| JP6903585B2 (ja) | 2015-03-13 | 2021-07-14 | レスバーロジックス コーポレイション | 補体関連疾患の治療のための組成物および治療方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8719378D0 (en) * | 1987-08-15 | 1987-09-23 | Pfizer Ltd | Antiarrythmic agents |
| EP0894797A4 (en) * | 1997-01-09 | 2001-08-16 | Terumo Corp | NEW AMID DERIVATIVES AND INTERMEDIATES ON YOUR SYNTHESIS |
-
2001
- 2001-08-01 GB GBGB0118752.5A patent/GB0118752D0/en not_active Ceased
-
2002
- 2002-07-11 PA PA20028550301A patent/PA8550301A1/es unknown
- 2002-07-19 WO PCT/IB2002/002872 patent/WO2003011829A1/en active IP Right Grant
- 2002-07-19 PL PL02368520A patent/PL368520A1/xx not_active Application Discontinuation
- 2002-07-19 EP EP02745749A patent/EP1412331B1/en not_active Expired - Lifetime
- 2002-07-19 CZ CZ2004151A patent/CZ2004151A3/cs unknown
- 2002-07-19 HU HU0401573A patent/HUP0401573A3/hu unknown
- 2002-07-19 RU RU2004102692/04A patent/RU2261861C1/ru not_active IP Right Cessation
- 2002-07-19 JP JP2003517021A patent/JP2005501054A/ja active Pending
- 2002-07-19 CN CNA028143256A patent/CN1533378A/zh active Pending
- 2002-07-19 AT AT02745749T patent/ATE323677T1/de not_active IP Right Cessation
- 2002-07-19 DE DE60210778T patent/DE60210778T2/de not_active Expired - Fee Related
- 2002-07-19 US US10/199,755 patent/US7026479B2/en not_active Expired - Fee Related
- 2002-07-19 MX MXPA04000978A patent/MXPA04000978A/es active IP Right Grant
- 2002-07-19 ES ES02745749T patent/ES2260457T3/es not_active Expired - Lifetime
- 2002-07-19 IL IL15899802A patent/IL158998A0/xx unknown
- 2002-07-19 KR KR10-2004-7001513A patent/KR20040019097A/ko not_active Application Discontinuation
- 2002-07-19 BR BR0211670-7A patent/BR0211670A/pt not_active IP Right Cessation
- 2002-07-19 CA CA002451075A patent/CA2451075A1/en not_active Abandoned
- 2002-07-23 DO DO2002000443A patent/DOP2002000443A/es unknown
- 2002-07-26 PE PE2002000678A patent/PE20030346A1/es not_active Application Discontinuation
- 2002-07-29 EG EG2002070853A patent/EG23204A/xx active
- 2002-07-29 HN HN2002000197A patent/HN2002000197A/es unknown
- 2002-07-29 UY UY27399A patent/UY27399A1/es not_active Application Discontinuation
- 2002-07-31 AR ARP020102914A patent/AR036204A1/es unknown
- 2002-08-01 AP APAP/P/2002/002602A patent/AP1299A/en active
-
2003
- 2003-11-20 ZA ZA200309043A patent/ZA200309043B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2260457T3 (es) | 2006-11-01 |
| PE20030346A1 (es) | 2003-04-05 |
| PL368520A1 (en) | 2005-04-04 |
| MXPA04000978A (es) | 2004-04-20 |
| BR0211670A (pt) | 2004-07-13 |
| IL158998A0 (en) | 2004-05-12 |
| AP2002002602A0 (en) | 2002-09-30 |
| US7026479B2 (en) | 2006-04-11 |
| CN1533378A (zh) | 2004-09-29 |
| JP2005501054A (ja) | 2005-01-13 |
| CA2451075A1 (en) | 2003-02-13 |
| DE60210778D1 (de) | 2006-05-24 |
| DE60210778T2 (de) | 2007-01-04 |
| HUP0401573A2 (hu) | 2005-01-28 |
| EP1412331B1 (en) | 2006-04-19 |
| AP1299A (en) | 2004-09-06 |
| US20030100753A1 (en) | 2003-05-29 |
| EG23204A (en) | 2004-07-31 |
| AR036204A1 (es) | 2004-08-18 |
| UY27399A1 (es) | 2003-02-28 |
| RU2261861C1 (ru) | 2005-10-10 |
| DOP2002000443A (es) | 2003-02-15 |
| RU2004102692A (ru) | 2005-07-10 |
| ZA200309043B (en) | 2004-11-22 |
| GB0118752D0 (en) | 2001-09-26 |
| ATE323677T1 (de) | 2006-05-15 |
| EP1412331A1 (en) | 2004-04-28 |
| WO2003011829A1 (en) | 2003-02-13 |
| CZ2004151A3 (cs) | 2005-01-12 |
| KR20040019097A (ko) | 2004-03-04 |
| HUP0401573A3 (en) | 2005-06-28 |
| PA8550301A1 (es) | 2003-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27234A1 (es) | Inhibidores novedosos de tirosina cinasa | |
| LU92338I2 (fr) | Enzalutamide et ses sels pharmaceutiquement acceptables (XTANDI) | |
| NO20091661L (no) | Anvendelse av pegylert IL-10 for a behandle kreft | |
| HN2002000197A (es) | Proceso para la produccion de quinazolinas | |
| WO2008046083A3 (en) | Use of oxindole compounds as therapeutic agents | |
| CR7182A (es) | Benzoilsufanamidas y sulfonilbenzamidinas que se usan como agentes antitumorales | |
| CR7332A (es) | INHIBIDORES DEL FACTOR Xa Y DE OTRAS PROTEASAS DE SERINA IMPLICADAS EN LA CASCADA DE LA COAGULACION | |
| HRP20070567B1 (hr) | Heliks 12 usmjereni ne-steroidni antiandrogeni | |
| ECSP024382A (es) | Inhibidores de proteasa de serina | |
| HK1087613A1 (en) | Quinazoline derivatives and their use in the treatment of cancer | |
| CY1107674T1 (el) | Φαρμακευτικος συνδυασμος για τη θεραπευτικη αντιμετωπιση της καλοηθους υπερπλασιας του προστατη ή για την μακροπροθεσμη προληψη της οξειας επισχεσης ουρων | |
| BR122018009866B8 (pt) | métodos para preparar compostos de éter aminocicloexílico e compostos intermediários | |
| WO2008046082A3 (en) | Use of heterocyclic compounds as therapeutic agents | |
| HN2001000277A (es) | PIRROLO [2,1 - a] DIHIDROISOQUINOLINAS | |
| BRPI0407913A (pt) | antagonistas receptores de ccr-3 | |
| GT200100251A (es) | Procedimiento para la preparacion de imidazotriazinonas substituidas con sulfonamida | |
| MX2007006927A (es) | Combinacion de inhibidor de tirosina cinasa y her-2/neu para terapia de cancer. | |
| BR0109512A (pt) | Imidazopiridinas tricìclicas | |
| BRPI0415678A (pt) | compostos de pirimidina para o tratamento de inflamação | |
| DE602006020585D1 (de) | Neue cysteinproteasehemmer und ihre therapeutische anwendung | |
| MX2008001838A (es) | Sales y polimorfos de un inhibidor de vegf-r. | |
| HK1074840A1 (en) | Novel dithiolopyrrolones with therapeutic activity | |
| EA200401100A1 (ru) | 1α-ФТОР-25-ГИДРОКСИ-16,23E-ДИЕН-26,27-БИСГОМО-20-ЭПИХОЛЕКАЛЬЦИФЕРОЛ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ | |
| DK1521752T3 (da) | Makrocykliske forbindelser til behandling af cancer | |
| ATE319707T1 (de) | Verfahren zur herstellung von chinazolinen |